1. Home
  2. RAPT vs MDIA Comparison

RAPT vs MDIA Comparison

Compare RAPT & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • MDIA
  • Stock Information
  • Founded
  • RAPT 2015
  • MDIA 2019
  • Country
  • RAPT United States
  • MDIA United States
  • Employees
  • RAPT N/A
  • MDIA N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • MDIA Broadcasting
  • Sector
  • RAPT Health Care
  • MDIA Consumer Discretionary
  • Exchange
  • RAPT Nasdaq
  • MDIA Nasdaq
  • Market Cap
  • RAPT 65.6M
  • MDIA 59.3M
  • IPO Year
  • RAPT 2019
  • MDIA N/A
  • Fundamental
  • Price
  • RAPT $1.52
  • MDIA $1.15
  • Analyst Decision
  • RAPT Hold
  • MDIA
  • Analyst Count
  • RAPT 10
  • MDIA 0
  • Target Price
  • RAPT $5.00
  • MDIA N/A
  • AVG Volume (30 Days)
  • RAPT 920.1K
  • MDIA 56.7K
  • Earning Date
  • RAPT 11-12-2024
  • MDIA 11-26-2024
  • Dividend Yield
  • RAPT N/A
  • MDIA N/A
  • EPS Growth
  • RAPT N/A
  • MDIA N/A
  • EPS
  • RAPT N/A
  • MDIA N/A
  • Revenue
  • RAPT N/A
  • MDIA $45,884,000.00
  • Revenue This Year
  • RAPT N/A
  • MDIA N/A
  • Revenue Next Year
  • RAPT N/A
  • MDIA N/A
  • P/E Ratio
  • RAPT N/A
  • MDIA N/A
  • Revenue Growth
  • RAPT N/A
  • MDIA 22.80
  • 52 Week Low
  • RAPT $1.25
  • MDIA $0.40
  • 52 Week High
  • RAPT $27.35
  • MDIA $6.86
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 39.12
  • MDIA 34.73
  • Support Level
  • RAPT $1.31
  • MDIA $1.11
  • Resistance Level
  • RAPT $1.96
  • MDIA $1.34
  • Average True Range (ATR)
  • RAPT 0.37
  • MDIA 0.10
  • MACD
  • RAPT -0.09
  • MDIA 0.00
  • Stochastic Oscillator
  • RAPT 10.67
  • MDIA 0.00

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About MDIA Mediaco Holding Inc.

MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales and events including sponsorships and ticket sales, licensing, and syndication.

Share on Social Networks: